Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
University of Vermont
30 participants
Feb 5, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is: Does PE+ decrease PTSD symptoms? All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning. Participants will: * Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.
Eligibility
Inclusion Criteria5
- Female
- >18 years old
- Gestational age ≤ 25 weeks
- Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5
- Participants receiving psychotropic medications must be maintained on a stable dose for >14 days prior to enrollment.
Exclusion Criteria6
- Male
- Under 18 years old
- Gestational age > 25 weeks
- No current diagnosis of PTSD
- Current delusions or hallucinations, unstable bipolar disorder, imminent risk for suicide as assessed by the Mini International Neuropsychiatric Interview
- Enrolled in another ongoing evidence-based treatment for PTSD.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Prolonged exposure therapy plus incentives for therapy session attendance
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06670079